Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001415889-16-005478
Filing Date
2016-04-11
Accepted
2016-04-11 16:40:11
Documents
1
Effectiveness Date
2016-04-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8286
  Complete submission text file 0001415889-16-005478.txt   9468
Mailing Address 1410 BROADWAY, 23RD FLOOR NEW YORK CITY NY 10018
Business Address 1410 BROADWAY, 23RD FLOOR NEW YORK CITY NY 10018 917-842-2353
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-261048 | Film No.: 161565504
SIC: 2834 Pharmaceutical Preparations